Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System

Hypertension. 2020 Nov;76(5):e34-e36. doi: 10.1161/HYPERTENSIONAHA.120.15841. Epub 2020 Aug 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • COVID-19
  • Cohort Studies
  • Coronavirus Infections / blood*
  • Coronavirus Infections / drug therapy*
  • Female
  • Germany
  • Hospitalization / statistics & numerical data
  • Humans
  • Intensive Care Units / statistics & numerical data
  • Male
  • Middle Aged
  • Pandemics
  • Peptidyl-Dipeptidase A / analysis*
  • Pneumonia, Viral / blood*
  • Pneumonia, Viral / drug therapy*
  • Registries*
  • Renin-Angiotensin System / drug effects*
  • Retrospective Studies
  • Risk Assessment
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2